- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on 1. típusú neurofibromatosis
Total 5602 results
-
University of ValenciaUniversidade Federal do Rio Grande do Norte; University of TwenteUnknownPregnancy | Mental Health Wellness 1Spain
-
Hadassah Medical OrganizationUnknownUncontrolled Type 1 Diabetic Patients
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Instytut Diabetologii Sp. z o.o.National Center for Research and Development, Poland; Nalecz Institute of Biocybernetics...UnknownType 1 Diabetes Mellitus With Hyperglycemia | Type 1 Diabetes Mellitus With HypoglycaemiaPoland
-
University of PittsburghNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedHealthy | Cognitive Function 1, SocialUnited States
-
University of PennsylvaniaCompletedMental Health Wellness 1 | LonelinessUnited States
-
Daewoong Pharmaceutical Co. LTD.CompletedPhase 1 Study, Healthy VolunteersKorea, Republic of
-
Universitat Jaume IEuropean Social Fund; Generalitat ValencianaCompletedCompassion | Mental Health Wellness 1Spain
-
University of Southern DenmarkRegion of Southern Denmark; Danish Council for Independent Research; The Faculty...CompletedMorphine | Organic Cation Transporter 1Denmark
-
Astellas Pharma Europe B.V.Completed
-
Assistance Publique - Hôpitaux de ParisCompletedRenal HYPODYSPLASIA, Nonsyndromic, 1France
-
University of SaskatchewanThe Hospital for Sick Children; University of Calgary; Children's Hospital of...Recruiting
-
Centre Hospitalier Universitaire DijonCompleted
-
Eddii, Inc.Completed
-
Scripps Translational Science InstituteCompletedHypertension | Hypertension, Grade 1 | Hypertension Treatment | N of 1 Study DesignUnited States
-
National Institute of Diabetes and Digestive and...CompletedType 1 Diabetes | Preservation of Insulin Secretion | Newly Diagnosed Type 1 Diabetes | Canakinumab in Type 1 DiabetesUnited States, Canada
-
Zhujiang HospitalNot yet recruitingEfficacy Endpoint: no New Cerebrovascular Adverse Events Within 1 Year | Safety Endpoint: no New Moderate or Serious Adverse Events Within 1 Year | All-cause Mortality Events (Within 1 Year) | Incident Ischemic Stroke Events (Within 1 Year) | New Hemorrhagic Stroke Events (Within 1 Year) | New... and other conditions
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
University of Campania "Luigi Vanvitelli"RecruitingType 1 Diabetes MellitusItaly
-
Radboud University Medical CenterActive, not recruitingType 1 Diabetes MellitusNetherlands
-
Centre Hospitalier Universitaire DijonCompleted
-
University of CambridgeCambridge University Hospitals NHS Foundation Trust; Nottingham University... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile...Completed
-
Imperial College LondonDexCom, Inc.UnknownType 1 Diabetes MellitusUnited Kingdom
-
Institut de Recherches Cliniques de MontrealCompletedType 1 Diabetes MellitusCanada
-
Boston Children's HospitalCompletedType 1 Diabetes MellitusUnited States
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
Vanderbilt University Medical CenterCompletedType 1 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Germany, Belgium, Canada, Japan, Chile, United Kingdom, Poland, Netherlands, Argentina, Sweden, Russian Federation, Switzerland
-
AstraZenecaCompletedType 1 Diabetes MellitusJapan
-
Biocon LimitedTerminatedType 1 Diabetes MellitusIndia
-
Joslin Diabetes CenterNovo Nordisk A/STerminatedType 1 Diabetes MellitusUnited States
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompleted
-
University of PadovaAzienda Ospedaliera di PadovaCompletedType 1 Diabetes MellitusItaly
-
Sansum Diabetes Research InstituteUniversity of Virginia; University of California, Santa BarbaraCompleted
-
Legacy Health SystemJuvenile Diabetes Research FoundationCompleted
-
Kaplan Medical CenterUnknown
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
S-Evans Biosciences Co., Ltd.Wenzhou Medical University; Zhejiang University; Zhenjiang First People's HospitalUnknownType 1 Diabetes MellitusChina
-
University Hospital, GenevaSwiss National Science FoundationCompletedType 1 Diabetes MellitusSwitzerland
-
Boston University Charles River CampusMassachusetts General Hospital; University of Illinois at Chicago; Utah State...RecruitingMental Health Wellness 1 | Adolescent BehaviorUnited States
-
Guohui LiRecruitingPD-1 | Immune Related Adverse EventsChina
-
University of Southern DenmarkCompletedMetformin | Organic Cation Transporter 1 | CodeineDenmark
-
OPKO Health, Inc.Elan PharmaceuticalsTerminatedBipolar 1 DisorderUnited States, Bulgaria, Canada, Czechia, France, Poland, Romania, Spain, Turkey
-
The University of Hong KongCompleted
-
Bispebjerg HospitalUniversity of Copenhagen; Duke University; The Ministry of Science, Technology... and other collaboratorsCompletedCarboxylesterase 1 (CES1) Genotype | CES1 ActivityDenmark
-
St. Olavs HospitalRecruiting
-
Chang Gung UniversityChang Gung Memorial HospitalRecruiting
-
Poznan University of Medical SciencesRecruitingType 1 Diabetes MellitusPoland
-
Rabin Medical CenterDreaMed DiabetesTerminated